Trademark: 88639660
Status Date
Monday, February 15, 2021
Filing Date
Wednesday, October 2, 2019
Published for Opposition
Tuesday, May 19, 2020
Abandoned Date
Monday, February 15, 2021
1 Assays for testing tissue samples and bodily fluids for scientific research in the field of cancer detection, analysis and prognosis; diagnostic assays for testing tissue samples and bodily fluids for scientific research in the field of cancer detection, analysis and prognosis; clinical diagnostic reagents; reagents for scientific or medical research use, namely, reagents for use in preparation of RNA samples; kits consisting primarily of enzymes for scientific and research purposes, and also including nucleic acids, buffers, reagents and assays for use in disease testing; diagnostic kits comprised primarily of diagnostic reagents for clinical or medical laboratory use and diagnostic assays for testing tissue samples and bodily fluids for clinical or medical laboratory use in cancer detection, analysis and prognosis; diagnostic kits comprised primarily of enzymes for scientific and research purposes, and also including nucleic acids, buffers, reagents and assays for use in disease testing; clinical diagnostic reagents
5 Diagnostic kits comprised of medical diagnostic reagents and diagnostic assays for testing tissue samples and bodily fluids for use in cancer detection, analysis and prognosis; medical reagents; medical diagnostic reagents; kits for medical diagnostic purposes consisting primarily of enzymes for medical purposes, and also including nucleic acids, buffers, reagents and assays for use in disease testing and classification; diagnostic kits consisting primarily of enzymes for medical purposes, and also including nucleic acids, buffers, reagents and assays for use in disease testing and classification; medical diagnostic assays for testing of bodily fluids and tissue samples for use in disease detection and testing for medical and prognostic purposes; medical diagnostic reagents and assays for testing bodily fluids and tissue samples for use in disease testing and classification; enzyme preparations for medical purposes; biological preparations for the detection, diagnosis and monitoring of cancer for medical purposes; preparations for detecting genetic predispositions for medical purposes; biological preparations for use in the diagnosis, analysis and prognosis of cancer for medical purposes; diagnostic agents, preparations and substances for medical purposes
42 Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical testing services and information in the field of cancer research and disease classification
44 Medical testing for diagnostic and prognostic purposes in the field of cancer and disease classification; providing medical information to medical professionals in the form of reports in the field of cancer and disease classification
Feb 16, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Feb 15, 2021
Abandonment - No Use Statement Filed
Jul 14, 2020
Noa E-Mailed - Sou Required From Applicant
Jun 19, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 19, 2020
Teas Change Of Correspondence Received
Jun 19, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 19, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 19, 2020
Teas Change Of Owner Address Received
May 19, 2020
Official Gazette Publication Confirmation E-Mailed
May 19, 2020
Published For Opposition
Apr 29, 2020
Notification Of Notice Of Publication E-Mailed
Apr 15, 2020
Approved For Pub - Principal Register
Apr 14, 2020
Teas/Email Correspondence Entered
Apr 14, 2020
Correspondence Received In Law Office
Apr 9, 2020
Assigned To Lie
Apr 1, 2020
Teas Response To Office Action Received
Nov 18, 2019
Notification Of Non-Final Action E-Mailed
Nov 18, 2019
Non-Final Action E-Mailed
Nov 18, 2019
Non-Final Action Written
Nov 11, 2019
Assigned To Examiner
Oct 6, 2019
New Application Office Supplied Data Entered In Tram
Oct 5, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
